WST vs. DHR
Compare and contrast key facts about West Pharmaceutical Services, Inc. (WST) and Danaher Corporation (DHR).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: WST or DHR.
Correlation
The correlation between WST and DHR is 0.40, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
WST vs. DHR - Performance Comparison
Loading data...
Key characteristics
WST:
-0.71
DHR:
-0.86
WST:
-0.67
DHR:
-1.03
WST:
0.87
DHR:
0.87
WST:
-0.65
DHR:
-0.60
WST:
-1.75
DHR:
-1.37
WST:
22.17%
DHR:
17.49%
WST:
54.91%
DHR:
29.81%
WST:
-59.29%
DHR:
-65.30%
WST:
-53.63%
DHR:
-32.42%
Fundamentals
WST:
$15.14B
DHR:
$136.66B
WST:
$6.37
DHR:
$5.17
WST:
33.07
DHR:
36.93
WST:
3.54
DHR:
1.87
WST:
5.23
DHR:
5.74
WST:
5.64
DHR:
2.69
WST:
$2.90B
DHR:
$23.82B
WST:
$1.00B
DHR:
$14.23B
WST:
$729.50M
DHR:
$7.17B
Returns By Period
In the year-to-date period, WST achieves a -33.76% return, which is significantly lower than DHR's -14.44% return. Over the past 10 years, WST has underperformed DHR with an annualized return of 15.27%, while DHR has yielded a comparatively higher 18.73% annualized return.
WST
-33.76%
3.69%
-31.00%
-38.64%
0.47%
15.27%
DHR
-14.44%
2.86%
-14.69%
-25.60%
6.63%
18.73%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
WST vs. DHR — Risk-Adjusted Performance Rank
WST
DHR
WST vs. DHR - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for West Pharmaceutical Services, Inc. (WST) and Danaher Corporation (DHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
WST vs. DHR - Dividend Comparison
WST's dividend yield for the trailing twelve months is around 0.38%, less than DHR's 0.58% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
WST West Pharmaceutical Services, Inc. | 0.38% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% | 0.77% |
DHR Danaher Corporation | 0.58% | 0.47% | 0.43% | 0.38% | 0.26% | 0.32% | 0.44% | 0.62% | 0.60% | 36.46% | 0.80% | 0.47% |
Drawdowns
WST vs. DHR - Drawdown Comparison
The maximum WST drawdown since its inception was -59.29%, smaller than the maximum DHR drawdown of -65.30%. Use the drawdown chart below to compare losses from any high point for WST and DHR. For additional features, visit the drawdowns tool.
Loading data...
Volatility
WST vs. DHR - Volatility Comparison
West Pharmaceutical Services, Inc. (WST) and Danaher Corporation (DHR) have volatilities of 11.24% and 11.35%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
WST vs. DHR - Financials Comparison
This section allows you to compare key financial metrics between West Pharmaceutical Services, Inc. and Danaher Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
WST vs. DHR - Profitability Comparison
WST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported a gross profit of 231.90M and revenue of 698.00M. Therefore, the gross margin over that period was 33.2%.
DHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Danaher Corporation reported a gross profit of 3.51B and revenue of 5.74B. Therefore, the gross margin over that period was 61.2%.
WST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported an operating income of 107.00M and revenue of 698.00M, resulting in an operating margin of 15.3%.
DHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Danaher Corporation reported an operating income of 1.27B and revenue of 5.74B, resulting in an operating margin of 22.2%.
WST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported a net income of 89.80M and revenue of 698.00M, resulting in a net margin of 12.9%.
DHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Danaher Corporation reported a net income of 954.00M and revenue of 5.74B, resulting in a net margin of 16.6%.